Capricor Therapeutics
CAPR
#7633
Rank
A$0.66 B
Marketcap
A$11.47
Share price
0.80%
Change (1 day)
28.79%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2026 (TTM): A-$3.61

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$3.70. In 2025 the company made an earnings per share (EPS) of A-$3.41 a decrease over its 2024 EPS that were of A-$1.81.

EPS history for Capricor Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$3.615.66%
2025A-$3.4188.33%
2024A-$1.81
2022A-$1.7835.63%
2021A-$1.31-7.45%
2020A-$1.42-55.45%
2019A-$3.19-59.81%
2018A-$7.93-1850%
2017A$0.45-102.94%
2016A-$15.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.09-372.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$10.53-384.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A-$9.13 146.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.57 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A-$11.41 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$44.25 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA